Cargando…

Alemtuzumab in chronic lymphocytic leukemia

QUESTIONS: With respect to outcomes such as survival, response rate, response duration, time to progression, and quality of life, is alemtuzumab a beneficial treatment option for patients with B-cell chronic lymphocytic leukemia (cll)? What toxicities are associated with the use of alemtuzumab? Whic...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fraser, G., Smith, C.A., Imrie, K., Meyer, R.
Formato:	Texto
Lenguaje:	English
Publicado:	Multimed Inc. 2007
Materias:	Practice Guideline Series
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1899355/ https://www.ncbi.nlm.nih.gov/pubmed/17593982

Ejemplares similares

Bortezomib in multiple myeloma and lymphoma: a systematic review and clinical practice guideline
por: Reece, D., et al.
Publicado: (2006)

(131)I–Tositumomab in lymphoma
por: Cheung, M.C., et al.
Publicado: (2009)

Treatment of depression in cancer patients
por: Rodin, G., et al.
Publicado: (2007)

A framework for the organization and delivery of systemic treatment
por: Vandenberg, T., et al.
Publicado: (2009)

Guidelines for the diagnosis and management of carcinoid tumours. Part 1: The gastrointestinal tract. A statement from a Canadian National Carcinoid Expert Group
por: Maroun, J., et al.
Publicado: (2006)

Clinician–patient communication: evidence-based recommendations to guide practice in cancer
por: Rodin, G., et al.
Publicado: (2009)

Biochemotherapy for the treatment of metastatic malignant melanoma: a clinical practice guideline
por: Verma, S., et al.
Publicado: (2008)

Management of single brain metastasis: a practice guideline
por: Mintz, A., et al.
Publicado: (2007)

The role of the epidermal growth factor receptor tyrosine kinase inhibitors as therapy for advanced, metastatic, and recurrent non-small-cell lung cancer: a Canadian national consensus statement
por: Ellis, P.M., et al.
Publicado: (2009)

Gliadel wafers in the treatment of malignant glioma: a systematic review
por: Perry, J., et al.
Publicado: (2007)

Single-agent interleukin-2 in the treatment of metastatic melanoma
por: Petrella, T., et al.
Publicado: (2007)

Preparation with recombinant humanized thyroid-stimulating hormone before radioiodine ablation after thyroidectomy: a systematic review
por: Yoo, J., et al.
Publicado: (2009)

The use of prophylactic anticonvulsants in patients with brain tumours—a systematic review
por: Perry, J., et al.
Publicado: (2006)

First-line treatment of chronic lymphocytic leukemia: role of alemtuzumab
por: Schweighofer, Carmen Diana, et al.
Publicado: (2010)

Cardiac management during adjuvant trastuzumab therapy: recommendations of the Canadian Trastuzumab Working Group
por: Mackey, J.R., et al.
Publicado: (2008)

Canadian supportive care recommendations for the management of neutropenia in patients with cancer
por: Kouroukis, C.T., et al.
Publicado: (2008)

Temozolomide for the treatment of metastatic melanoma
por: Quirbt, I., et al.
Publicado: (2007)

Canadian supportive care recommendations for the management of anemia in patients with cancer
por: Mikhael, J., et al.
Publicado: (2007)

Updated recommendations from the Canadian National Consensus Meeting on HER2/neu testing in breast cancer
por: Hanna, W., et al.
Publicado: (2007)

Adjuvant hormonal therapy for stage I endometrial cancer
por: Gien, L., et al.
Publicado: (2008)

Cancer antigen 125 in ovarian cancer surveillance: a decision analysis model
por: Hopkins, M.L., et al.
Publicado: (2007)

Optimal use of taxanes in metastatic breast cancer
por: King, K.M., et al.
Publicado: (2009)

Role of oxaliplatin combined with 5-fluorouracil and folinic acid in the first- and second-line treatment of advanced colorectal cancer
por: Jonker, D., et al.
Publicado: (2006)

Management of skin rash during egfr-targeted monoclonal antibody treatment for gastrointestinal malignancies: Canadian recommendations
por: Melosky, B., et al.
Publicado: (2009)

The role of her2-targeted therapies in women with her2-overexpressing metastatic breast cancer
por: Dent, S., et al.
Publicado: (2009)

The role of neoadjuvant her2-targeted therapies in her2-overexpressing breast cancers
por: Lemieux, J., et al.
Publicado: (2009)

Canadian recommendations for the treatment of glioblastoma multiforme
por: Mason, W.P., et al.
Publicado: (2007)

Ifosfamide-based combination chemotherapy in advanced soft-tissue sarcoma: a practice guideline
por: Verma, S., et al.
Publicado: (2007)

Dose-intensive chemotherapy with growth factor or autologous bone marrow or stem-cell transplant support in first-line treatment of advanced or metastatic adult soft tissue sarcoma: a clinical practice guideline
por: Verma, S., et al.
Publicado: (2008)

Optimal chemotherapy treatment for women with recurrent ovarian cancer
por: Fung-Kee-Fung, M., et al.
Publicado: (2007)

Pseudohyperkalemia in chronic lymphocytic leukemia
por: Gudgeon, Patrick, et al.
Publicado: (2023)

Colorectal Cancer Association of Canada consensus meeting: raising the standards of care for early-stage rectal cancer
Publicado: (2009)

Norovirus-related chronic diarrhea in a patient treated with alemtuzumab for chronic lymphocytic leukemia
por: Ronchetti, Anne-Marie, et al.
Publicado: (2014)

Alemtuzumab in the treatment of fludarabine refractory B-cell chronic lymphocytic leukemia (CLL)
por: Montillo, Marco, et al.
Publicado: (2008)

Management of adverse renal events related to alemtuzumab treatment in multiple sclerosis: a Belgian consensus
por: Sprangers, Ben, et al.
Publicado: (2017)

Summary of the Standards, Options and Recommendations for the management of patients with carcinoma of unknown primary site (2002)
por: Bugat, R, et al.
Publicado: (2003)

Management of immune thrombocytopenia in multiple sclerosis patients treated with alemtuzumab: a Belgian consensus
por: Lambert, Catherine, et al.
Publicado: (2018)

Multidisciplinary guidelines for the care of late preterm infants
por: Phillips, R M, et al.
Publicado: (2013)

Standards, Options and Recommendations for the use of appetite stimulants in oncology (2000)
por: Desport, J C, et al.
Publicado: (2003)

Summary of the Standards, Options and Recommendations for nutritional support in patients undergoing bone marrow transplantation (2002)
por: Raynard, B, et al.
Publicado: (2003)

Cannot write session to /tmp/vufind_sessions/sess_ib676fho3ici04f3ggstv7uteo